Kim Kozlowski
The Detroit News

Ann Arbor — Inside a laboratory at the University of Michigan, researchers have been injecting stem cells into the brains of mice engineered to have Alzheimer’s disease, and making remarkable discoveries.

The experiments are among the first in the nation to examine how stem cell therapies might alter the course of Alzeheimer’s, a fatal disease that afflicts more than 5 million people in the U.S. and is widely regarded as an epidemic predicted to explode as the nation’s population ages.

The research is being overseen by UM’s Dr. Eva Feldman, who pioneered the nation’s first clinical trial using stem cells in patients with amyotrophic lateral sclerosis — a disease that received global awareness last summer thanks to the ALS ice bucket challenge… Read more here.

 

feldman

Dr. Feldman(Photo: David Guralnick , The Detroit News)

About the author

Comments are closed.